|Labeler Name||Mission Pharmacal Company|
|Dosage & Substance||tablet ascorbic acid; iron; vitamin d; .alpha.-tocopherol acetate; thiamine; riboprine; niacinamide; pyridoxine hydrochloride; folic acid; potassium triiodide; zinc oxide; cupric oxide; docusate sodium; calcium citrate|
|Date First Marketed||April 11, 2014|
CitraNatal® 90 DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.
WARNING: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.